aTyr Pharma | LIFE - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Ardelyx USD 381.87M 447K 2026-03
aTyr Pharma USD 58.36M 9.21M 2026-06
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Cipla INR 250.61B 9.14B 2026-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Curis USD 16.61M 9.7M 2026-03
GlaxoSmithKline GBP 17.9B 336M 2026-09
Grifols EUR 5.96B 316.31M 2025-12
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Novartis USD 27.35B 744M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06